Research and Development
For more than 100 years, Roche has built a legacy of innovation decade by decade, discovery by discovery, and we continue to focus on developing new, innovative and clinically differentiated medicines that are beneficial for healthcare professionals and patients. Roche continues to focus on cutting edge research that will provide benefits to patients. As such, the company spent 8.4 billion Swiss francs ($9B US) on Research and Development in 2012 and employed over 18,200 people in R&D.
Roche also has a unique R&D network model and strong alliances with companies, universities and research institutions worldwide, which gives our scientists the broadest access to innovation. In the area of personalized medicine, Roche is also a pioneer.
For more information about Roche research, click here.